Back to Companies
NeuroSense Therapeutics Ltd.
NRSNNasdaqCIK: 0001875091
NeuroSense Therapeutics Ltd. (NRSN) shows 13 recent insider filings from 10 insiders, with no open-market buying or selling. Binder Hagit (General Manager) is the most active by dollar volume. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$0
Purchases
$0
Sales
$0
Unique Insiders
10
Recent Insider Trades
13 loaded
| Mar 30 | NRSN NeuroSense Therapeutics Ltd. | Binder Hagit | General Manager | Grant | $0 |
| Apr 1 | NRSN NeuroSense Therapeutics Ltd. | Eisenberg Or | Chief Financial Officer | Grant | $0 |
| Mar 30 | NRSN NeuroSense Therapeutics Ltd. | Russek-Blum Niva | Chief Technology Officer | Grant | $0 |
| Mar 18 | NRSN NeuroSense Therapeutics Ltd. | Leuchtenberger Mark | Director | Other | $0 |
| Mar 30 | NRSN NeuroSense Therapeutics Ltd. | Russek-Blum Niva | Chief Technology Officer | Other | $0 |
| Mar 31 | NRSN NeuroSense Therapeutics Ltd. | Mandil-Levin Revital | Director | Other | $0 |
| Mar 30 | NRSN NeuroSense Therapeutics Ltd. | Ben-Noon Alon | Chief Executive Officer, 10% Owner | Other | $0 |
| Mar 18 | NRSN NeuroSense Therapeutics Ltd. | Claiborne Cary J | Director | Other | $0 |
| Mar 18 | NRSN NeuroSense Therapeutics Ltd. | Tracik Ferenc | Chief Medical Officer | Other | $0 |
| Mar 18 | NRSN NeuroSense Therapeutics Ltd. | Pellizzari Christine A | Director | Other | $0 |
| Mar 18 | NRSN NeuroSense Therapeutics Ltd. | Binder Hagit | General Manager | Other | $0 |
| Mar 18 | NRSN NeuroSense Therapeutics Ltd. | Golan Roy | Director | Other | $0 |
| Apr 1 | NRSN NeuroSense Therapeutics Ltd. | Eisenberg Or | Chief Financial Officer | Other | $0 |
13 filings